JP2019156859A5 - - Google Patents

Download PDF

Info

Publication number
JP2019156859A5
JP2019156859A5 JP2019123542A JP2019123542A JP2019156859A5 JP 2019156859 A5 JP2019156859 A5 JP 2019156859A5 JP 2019123542 A JP2019123542 A JP 2019123542A JP 2019123542 A JP2019123542 A JP 2019123542A JP 2019156859 A5 JP2019156859 A5 JP 2019156859A5
Authority
JP
Japan
Prior art keywords
buprenorphine
subject
mucoadhesive
minutes
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019123542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019156859A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019156859A publication Critical patent/JP2019156859A/ja
Publication of JP2019156859A5 publication Critical patent/JP2019156859A5/ja
Priority to JP2021090747A priority Critical patent/JP2021121639A/ja
Pending legal-status Critical Current

Links

JP2019123542A 2008-06-23 2019-07-02 多方向性粘膜送達装置および使用法 Pending JP2019156859A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021090747A JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7491808P 2008-06-23 2008-06-23
US61/074,918 2008-06-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016215881A Division JP2017019878A (ja) 2008-06-23 2016-11-04 多方向性粘膜送達装置および使用法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021090747A Division JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Publications (2)

Publication Number Publication Date
JP2019156859A JP2019156859A (ja) 2019-09-19
JP2019156859A5 true JP2019156859A5 (https=) 2020-03-19

Family

ID=41550666

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011516543A Pending JP2011525536A (ja) 2008-06-23 2009-06-23 多方向性粘膜送達装置および使用法
JP2014230432A Pending JP2015052003A (ja) 2008-06-23 2014-11-13 多方向性粘膜送達装置および使用法
JP2016215881A Pending JP2017019878A (ja) 2008-06-23 2016-11-04 多方向性粘膜送達装置および使用法
JP2019123542A Pending JP2019156859A (ja) 2008-06-23 2019-07-02 多方向性粘膜送達装置および使用法
JP2021090747A Pending JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2011516543A Pending JP2011525536A (ja) 2008-06-23 2009-06-23 多方向性粘膜送達装置および使用法
JP2014230432A Pending JP2015052003A (ja) 2008-06-23 2014-11-13 多方向性粘膜送達装置および使用法
JP2016215881A Pending JP2017019878A (ja) 2008-06-23 2016-11-04 多方向性粘膜送達装置および使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021090747A Pending JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Country Status (9)

Country Link
US (7) US20110189259A1 (https=)
EP (1) EP2293751B1 (https=)
JP (5) JP2011525536A (https=)
CN (2) CN105833420A (https=)
AU (1) AU2009271271A1 (https=)
BR (1) BRPI0915386B8 (https=)
CA (1) CA2728912C (https=)
ES (1) ES2663777T3 (https=)
WO (1) WO2010008863A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
RU2504377C2 (ru) 2006-07-21 2014-01-20 БайоДеливери Сайенсиз Интэнэшнл, Инк. Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8601691B2 (en) 2011-04-27 2013-12-10 General Electric Company Component and methods of fabricating a coated component using multiple types of fillers
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
US20130086784A1 (en) 2011-10-06 2013-04-11 General Electric Company Repair methods for cooled components
KR20190110628A (ko) * 2011-12-21 2019-09-30 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 만성 통증 완화에 이용되는 점막 관통 약물 전달 장치
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9435208B2 (en) 2012-04-17 2016-09-06 General Electric Company Components with microchannel cooling
WO2013171146A1 (en) * 2012-05-15 2013-11-21 Lts Lohmann Therapie-Systeme Ag Oral film containing enteric release opiate resinate
KR20140030526A (ko) * 2012-08-31 2014-03-12 동국대학교 산학협력단 유동적 위장관점막 부착성 경구투여용 제형
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
DK3043777T3 (da) 2013-09-10 2020-07-20 Fresh Cut Dev Llc Sublingual buprenorphinspray
CA2954370A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US9956323B2 (en) 2014-12-18 2018-05-01 Cook Medical Technologies Llc Medical devices for local bioactive delivery
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
EP3685859A4 (en) 2017-09-22 2021-07-07 Medrx Co., Ltd. NON-STICKABLE ADHESIVE STAMP
US11452798B2 (en) 2017-09-27 2022-09-27 Cook Medical Technologies Llc Crosslinking submucosal injectate system
GB2574878A (en) * 2018-06-22 2019-12-25 Biofilm Ltd Oral compositions and mucoadhesive thin films formed therefrom
CN109276333B (zh) * 2018-10-25 2021-02-26 杭州口腔医院集团有限公司 用于口腔种植修复附着龈增宽的装置及方法
JP2022550869A (ja) * 2019-10-02 2022-12-05 ハイドロオクシス ホールディングス リミテッド 耐久性のある膜、それらの調製及び使用
EP3936112A1 (en) * 2020-07-07 2022-01-12 Occlugel Hydrophilic degradable microspheres for delivering buprenorphine
EP4422607A4 (en) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
JPS5770816A (en) * 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
US4582384A (en) 1984-05-04 1986-04-15 Amp Incorporated Overmolded shielded connector
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
JP2656338B2 (ja) * 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
JP3197035B2 (ja) * 1991-12-10 2001-08-13 積水化学工業株式会社 口腔粘膜適用製剤
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
EP0750905B1 (en) * 1995-06-27 2003-01-02 Kao Corporation Patch comprising water soluble adhesive sheet
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19652188C2 (de) * 1996-12-16 2002-02-14 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
IL135258A0 (en) * 1997-09-26 2001-05-20 Noven Pharma Bioadhesive compositions and methods for topical administration of active agents
EP1041987B1 (en) * 1997-12-22 2006-04-19 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
EP1041988A4 (en) * 1997-12-22 2002-03-13 Euro Celtique Sa METHOD FOR PREVENTING ABUSE OF OPIOID DOSES FORMS
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6227384B1 (en) 1999-04-30 2001-05-08 Haworth, Inc. Slotted divider arrangement
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
US20020022048A1 (en) * 2000-05-26 2002-02-21 Bromberg Lev E. Composite wafer for controlled drug delivery
JP4850346B2 (ja) * 2001-03-15 2012-01-11 救急薬品工業株式会社 粘膜貼付剤
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
SE0300187D0 (sv) * 2003-01-24 2003-01-24 Magle Ab A smokeless tobacco substitute material
SE0302947D0 (sv) * 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
US8173840B2 (en) * 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
US20050042281A1 (en) * 2003-08-21 2005-02-24 Singh Nikhilesh N. Compositions for delivering therapeutic agents across the oral mucosa
US7470397B2 (en) * 2003-10-24 2008-12-30 Adhesives Research, Inc. Disintegratable films for diagnostic devices
CA2543610A1 (en) * 2003-10-30 2005-05-19 Alza Corporation Transdermal analgesic systems having reduced abuse potential
EP1691746B1 (en) * 2003-12-08 2015-05-27 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
JP4727499B2 (ja) * 2005-07-13 2011-07-20 日本電子株式会社 走査型プローブ顕微鏡及びその動作方法
BRPI0619806A2 (pt) * 2005-12-13 2011-10-18 Biodelivery Sciences Int Inc dispositivo para fornecimento de fármacos transmucosal resistente ao abuso
RU2504377C2 (ru) * 2006-07-21 2014-01-20 БайоДеливери Сайенсиз Интэнэшнл, Инк. Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
DK2101740T3 (da) * 2006-12-04 2013-11-18 Orexo Ab Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider
GB2447015A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition comprising a specific ratio of buprenorphine and naltrexone

Similar Documents

Publication Publication Date Title
JP2019156859A5 (https=)
JP2011525536A5 (https=)
JP2009544619A5 (https=)
JP2009536147A5 (https=)
WO2007125545A2 (en) Transmucosal composition
RU2019118034A (ru) Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
JP2010535805A5 (https=)
JP2009539761A5 (https=)
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
JP2012513955A5 (https=)
CN102056578A (zh) 多向粘膜给药装置及使用方法
JP2015528504A5 (https=)
WO2004091512A3 (en) Abuse-resistant oral dosage forms and method of use thereof
JP2008505857A5 (https=)
JP7174067B2 (ja) 多層経口薄膜
Mathew Oral local drug delivery: An overview
JP2010520183A5 (https=)
US20100221313A1 (en) Transdermal reservoir patch
CN1829482A (zh) 治疗依赖戒断
ZA200706640B (en) Method for a treatment with a medicament combination and medicament combinations suitable for the same
EP1295598A1 (en) Pharmaceutical composition containing two active ingredients for smoking cessation
JP2015515974A5 (https=)
US20220184841A1 (en) Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
CN1829489A (zh) 术后疼痛的术前治疗
JP2006528190A5 (https=)